{"authors": ["Gina Kolata"], "date_download": "2022-10-25 23:23:02", "date_modify": "2022-10-25 23:23:02", "date_publish": "2020-05-23 19:10:58", "description": "A clinical trial led to the authorization of the only drug shown to work in Covid-19 patients. But until now, few experts had seen the numbers.", "filename": "2020_05_23_health_coronavirus-remdesivir_1666740182.html", "image_url": "https://static01.nyt.com/images/2020/05/23/science/23virus-remdesivir/23virus-remdesivir-facebookJumbo.jpg?year=2020&h=549&w=1050&s=153f2e51221367cdc4edd39d618788126e2d70a4dc636594923d7e4fd5e831db&k=ZQJBKqZ0VN", "language": "en", "localpath": "/Users/matthewwhite/news-please-repo//data/2022/10/25/nytimes.com/2020_05_23_health_coronavirus-remdesivir_1666740182.html", "title": "Remdesivir Coronavirus Trial: Federal Scientists Finally Publish Data", "title_page": "Remdesivir Coronavirus Trial: Federal Scientists Finally Publish Data - The New York Times", "title_rss": "NULL", "source_domain": "nytimes.com", "maintext": "Nearly a month after federal scientists claimed that an experimental drug had helped patients severely ill with the coronavirus, the research has been published.\nThe drug, remdesivir, was quickly authorized by the Food and Drug Administration for treatment of coronavirus patients, and hospitals rushed to obtain supplies.\nBut until now, researchers and physicians had not seen the actual data. And remdesivir, made by Gilead Sciences, has a spotty history. It was originally intended to treat hepatitis, but it failed to. It was tested against Ebola, but results were lackluster.\nSo far, remdesivir has not been officially approved for any purpose. The F.D.A.â€™s emergency use authorization was not a formal approval.", "url": "https://www.nytimes.com/2020/05/23/health/coronavirus-remdesivir.html"}